Adult-dose EpiPens are once again in short supply in Canada as manufacturing issues persist at a Pfizer plant that produces them for Mylan.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,